MLchartDataset catalogue

Patent · US4636524A · A · US

Cross-linked gels of hyaluronic acid and products containing such gels

(11) Publication number
US4636524A
(21) Application number
06/709,977
(22) Filing date
1985-03-08
(30) Priority date
1984-12-06
(43) Publication date
1987-01-13
(45) Date of grant
1987-01-13
(51) IPC
A61K 47/36; A61K 8/73; A61K 9/00; A61Q 19/00; C08B 37/08; C08F 8/34; C08L 5/08
(52) CPC
  • A61K Preparations for medical, dental or toiletry purposes: 8/042, 47/36, 8/73, 8/731, 8/735, 9/0014
  • A61Q Specific use of cosmetics or similar toiletry preparations: 19/00
  • C08B Polysaccharides; derivatives thereof: 37/0072
  • C08L Compositions of macromolecular compounds: 5/08
(73) Assignee
Biomatrix Inc
(72) Inventors
Endre A. Balazs; Adolf Leshchiner
(54) Title
Cross-linked gels of hyaluronic acid and products containing such gels
(57) Abstract

Disclosed are cross-linked gels of hyaluronic acid, alone or mixed with other hydrophilic polymers and containing various substances or covalently bonded low molecular weight substances and processes for preparing them. These products are useful in numerous applications including cosmetic formulations and as drug delivery systems.

Full text
View on Google Patents

Claims (1)

  1. A delivery system for a substance having biological or pharmacological activity, said system comprising a molecular cage formed of a cross-linked gel of hyaluronic acid or a mixed cross-linked gel of hyaluronic acid and at least one other hydrophilic polymer co-polymerizable therewith and having dispersed therein a substance having biological or pharmacological activity and which is capable of being diffused therefrom in a controlled manner.

Description

This application is a division of application Ser. No. 678,895, filed Dec. 6, 1984, now U.S. Pat. No. 4,582,865, issued Apr. 15, 1986.

1. Field of the Invention

The present invention relates to gels and mixed gels of hyaluronic acid (HA), formulations containing them and methods for preparing them.

2. The Prior Art

Hyaluronic acid is a well known, naturally occurring polysaccharide containing alternating N-acetyl-D-glucosamine and D-glucuronic acid monosaccharide units linked with β 1→4 bonds and the disaccharide units linked with β 1→3 glycoside bonds. Hyaluronic acid usually occurs as the sodium salt. The molecular weight of HA is generally within the range of 50,000 up to 8×10 6 and even higher.

The prior art describes the cross-linking of HA with the use of 1, 2, 3, 4-diepoxybutane in alkaline medium at 50° C. (T. C. Laurent, K. Hellsing, and B. Gelotte, Acta Chem. Scand. 18 [1984], No. 1, 274-5). The product obtained by that method is a gel which substantially swells in water.

It is also known that divinyl sulfone (DVS) is used for cross-linking polysaccharides, especially cellulose (U.S. Pat. No. 3,357,784).

FIG. 1 is a graphical representation of the experimental data set forth in Example 3 below; and

FIG. 2 is a graphical representation of the experimental data set forth in Example 4 below.

In one aspect thereof, the present invention provides highly swollen gels of cross-linked hyaluronic acid.

In another aspect, the invention provides mixed cross-linked gels of hyaluronic acid and other hydrophillic polymers.

Citations (6)

  • US3357784A
  • US4141973A
  • US4141973B1
  • US4303676A
  • US4487865A
  • US4500676A
Record as JSON
{
  "publication_number": "US4636524A",
  "country": "US",
  "kind": "A",
  "title": "Cross-linked gels of hyaluronic acid and products containing such gels",
  "abstract": "Disclosed are cross-linked gels of hyaluronic acid, alone or mixed with other hydrophilic polymers and containing various substances or covalently bonded low molecular weight substances and processes for preparing them. These products are useful in numerous applications including cosmetic formulations and as drug delivery systems.",
  "claims": [
    "1. A delivery system for a substance having biological or pharmacological activity, said system comprising a molecular cage formed of a cross-linked gel of hyaluronic acid or a mixed cross-linked gel of hyaluronic acid and at least one other hydrophilic polymer co-polymerizable therewith and having dispersed therein a substance having biological or pharmacological activity and which is capable of being diffused therefrom in a controlled manner."
  ],
  "description_excerpt": "This application is a division of application Ser. No. 678,895, filed Dec. 6, 1984, now U.S. Pat. No. 4,582,865, issued Apr. 15, 1986.\n\n1. Field of the Invention\n\nThe present invention relates to gels and mixed gels of hyaluronic acid (HA), formulations containing them and methods for preparing them.\n\n2. The Prior Art\n\nHyaluronic acid is a well known, naturally occurring polysaccharide containing alternating N-acetyl-D-glucosamine and D-glucuronic acid monosaccharide units linked with β 1→4 bonds and the disaccharide units linked with β 1→3 glycoside bonds. Hyaluronic acid usually occurs as the sodium salt. The molecular weight of HA is generally within the range of 50,000 up to 8×10 6 and even higher.\n\nThe prior art describes the cross-linking of HA with the use of 1, 2, 3, 4-diepoxybutane in alkaline medium at 50° C. (T. C. Laurent, K. Hellsing, and B. Gelotte, Acta Chem. Scand. 18 [1984], No. 1, 274-5). The product obtained by that method is a gel which substantially swells in water.\n\nIt is also known that divinyl sulfone (DVS) is used for cross-linking polysaccharides, especially cellulose (U.S. Pat. No. 3,357,784).\n\nFIG. 1 is a graphical representation of the experimental data set forth in Example 3 below; and\n\nFIG. 2 is a graphical representation of the experimental data set forth in Example 4 below.\n\nIn one aspect thereof, the present invention provides highly swollen gels of cross-linked hyaluronic acid.\n\nIn another aspect, the invention provides mixed cross-linked gels of hyaluronic acid and other hydrophillic polymers.",
  "cpc": [
    "A61K 8/042",
    "A61K 47/36",
    "A61K 8/73",
    "A61K 8/731",
    "A61K 8/735",
    "A61K 9/0014",
    "A61Q 19/00",
    "C08B 37/0072",
    "C08L 5/08"
  ],
  "ipc": [
    "A61K 47/36",
    "A61K 8/73",
    "A61K 9/00",
    "A61Q 19/00",
    "C08B 37/08",
    "C08F 8/34",
    "C08L 5/08"
  ],
  "assignees": [
    "Biomatrix Inc"
  ],
  "inventors": [
    "Endre A. Balazs",
    "Adolf Leshchiner"
  ],
  "filing_date": "1985-03-08",
  "publication_date": "1987-01-13",
  "grant_date": "1987-01-13",
  "priority_date": "1984-12-06",
  "application_number": "US-70997785-A",
  "family_id": "27102121",
  "cited_by_count": 275,
  "citations": [
    "US3357784A",
    "US4141973A",
    "US4141973B1",
    "US4303676A",
    "US4487865A",
    "US4500676A"
  ]
}

Record 7,487 of 8,000 in Patents full text (MLC-0201). Request the full dataset.